Moderna's AI-assisted mRNA cancer treatment succeeds in Phase 3 trial
KyeGomezB · x · 2026-08-20
Moderna and Merck's AI-assisted personalized mRNA cancer treatment has succeeded in a Phase 3 trial. The therapy sequences patient tumors, uses AI to identify mutations likely to trigger an immune response, and produces individualized mRNA treatments encoding up to 34 neoantigens. In the earlier Phase 2 trial for high-risk melanoma, it reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 59%.
More from Apps
- Robinhood's new Platinum card includes $250 annual Waymo ride credit — reed · 2026-10-16
- ChatGPT's missing UTM tags confirmed as a bug, traffic attribution fully restored — lilyraynyc · 2026-10-16
- Tolan hailed as the AI product Steve Jobs would have built, per viral essay — ajaymehta · 2026-10-16
- Design Studio Runs Agentic Workflows on FLORA Canvas, From Prototype to Shipped Site — round · 2026-10-16
- AI agents have a 'normal-people problem': most users won't hand over their lives — examachine · 2026-10-16
- She planned a Napa trip with an AI planner, changed everything last minute — 'at least the car drove itself' — katieruthmishra · 2026-10-16